Gui, G., Ravindra, N., Hegde, P. S., Andrew, G., Mukherjee, D., Wong, Z., Auletta, J. J., El Chaer, F., Chen, E. C., Chen, Y.-B., Corner, A., Devine, S. M., Iyer, S. G., Jimenez Jimenez, A. M., De Lima, M. J. G., Litzow, M. R., Kebriaei, P., Saber, W., Spellman, S. R., … Hourigan, C. S. (2024). Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-024-02447-4

Buso, H., Adam, E., Arkwright, P. D., Bhattad, S., Hamidieh, A. A., Behfar, M., Belot, A., Benezech, S., Chan, A. Y., Crow, Y. J., Dvorak, C. C., Flinn, A. M., Kapoor, U., Lankester, A., Kobayashi, M., Matsumura, R., Mottaghipisheh, H., Okada, S., Ouachee, M., … Gennery, A. R. (2024). Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working Party. Journal of Clinical Immunology, 45(1). https://doi.org/10.1007/s10875-024-01819-1

Kahn, J., Brazauskas, R., Bo-Subait, S., Buchbinder, D., Hamilton, B. K., Schoemans, H., Abraham, A. A., Agrawal, V., Auletta, J. J., Badawy, S. M., Beitinjaneh, A., Bhatt, N. S., Broglie, L., Diaz Perez, M. A., Farhadfar, N., Freytes, C. O., Gale, R. P., Ganguly, S., Hayashi, R. J., … Phelan, R. (2024). Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study. The Lancet Child & Adolescent Health, 8(10), 740–750. https://doi.org/10.1016/s2352-4642(24)00167-6

El Jurdi, N., Te, H. S., Cao, Q., Napurski, C., Wang, S., Robinson, A., Arora, M., ElHusseini, H., He, F., Niedernhofer, L. J., Thyagarajan, B., Prizment, A., Holtan, S., Blaes, A. H., & Yousefzadeh, M. J. (2024). Frailty and pre-frailty associated with long-term diminished physical performance and quality of life in breast cancer and hematopoietic cell transplant survivors. Aging, 16(18), 12432–12442. https://doi.org/10.18632/aging.206109

Williams, O. (2024). Hematopoietic cell transplantation for inborn errors of immunity: an update on approaches, outcomes and innovations. Current Opinion in Pediatrics, 36(6), 653–658. https://doi.org/10.1097/mop.0000000000001407

Goyal, A., O’Leary, D., Dabaja, B., Weng, W.-K., Zain, J., Cutler, C., Guitart, J., Kim, Y. H., Geskin, L. J., Hoppe, R. T., Wilson, L. D., Beaven, A. W., Horwitz, S., Allen, P. B., Barta, S. K., Bohjanen, K., Brammer, J. E., Carter, J. B., Comfere, N., … Foss, F. (2024). ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome. Transplantation and Cellular Therapy, 30(11), 1047–1060. https://doi.org/10.1016/j.jtct.2024.08.020

Rios, C. A. O., Qayed, M., Etra, A. M., Reshef, R., Newcomb, R., Yuhasz, N., Hexner, E. O., Aguayo-Hiraldo, P., Merli, P., Hogan, W. J., Weber, D., Kitko, C. L., Ayuk, F., Eder, M., Grupp, S. A., Kraus, S., Sandhu, K., Ullrich, E., Vasova, I., … Akahoshi, Y. (2024). Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients. Transplantation and Cellular Therapy, 30(11), 1061.e1-1061.e10. https://doi.org/10.1016/j.jtct.2024.08.019

George, S. A., Veludhandi, A., Xiang, Y., Liu, K., Stenger, E., Arnold, S. D., Mehta, A., Schirmer, D. A., Spencer, J. B., Guilcher, G. M. T., Bhatia, M., Abraham, A., Gomez-Lobo, V., Krishnamurti, L., & Meacham, L. R. (2024). Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 30(9), 912.e1-912.e13. https://doi.org/10.1016/j.jtct.2024.06.029

Arnold, S. D., Bakshi, N., Ross, D., Smith, C., Sinha, C., Veludhandi, A., Dutreuil, V., Bai, S., Meacham, L. R., Guilcher, G., Bhatia, M., Abraham, A., Kasow, K. A., Haight, A., El Rassi, F., Stenger, E., Lipscomb, J., & Krishnamurti, L. (2024). Long‐term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis. American Journal of Hematology, 99(10), 2037–2040. Portico. https://doi.org/10.1002/ajh.27436

Shanthikumar, S., Gower, W. A., Cooke, K. R., Bergeron, A., Schultz, K. R., Barochia, A., Tamae-Kakazu, M., Charbek, E., Reardon, E. E., Calvo, C., Casey, A., Cheng, P. C., Cole, T. S., Davies, S. M., Das, S., De, A., Deterding, R. R., Liptzin, D. R., Mechinaud, F., … Goldfarb, S. B. (2024). Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink? Transplantation and Cellular Therapy, 30(8), 760–769. https://doi.org/10.1016/j.jtct.2024.05.012

Abramova, R., Brown, M., Thomas, C., Salerno, D., Assal, A., & Campbell, P. (2023). Evaluation of a Protocol for Reducing Venous Thromboembolism in Hematopoietic Stem Cell Transplant Recipients. Journal of Pharmacy Practice, 37(4), 807–809. https://doi.org/10.1177/08971900231193531

Wang, W., Zhang, W., Su, L., Liu, L., Gao, Y., Wang, Q., Su, H., Song, Y., Zhang, H., Shen, J., Jing, H., Wang, S., Cen, X., Liu, H., Liu, A., Li, Z., Luo, J., He, J., Wang, J., … Zhou, D. (2024). Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China. Annals of Hematology, 103(8), 3061–3069. https://doi.org/10.1007/s00277-024-05708-w

Etra, A., El Jurdi, N., Katsivelos, N., Kwon, D., Gergoudis, S., Morales, G., Spyrou, N., Kowalyk, S., Aguayo-Hiraldo, P., Akahoshi, Y., Ayuk, F., Baez, J., Betts, B. C., Chanswangphuwana, C., Chen, Y.-B., Choe, H., DeFilipp, Z., Gleich, S., Hexner, E., … Holtan, S. (2024). Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD. Blood Advances, 8(12), 3284–3292. https://doi.org/10.1182/bloodadvances.2023011049

Nikiforow, S., Whangbo, J. S., Reshef, R., Tsai, D. E., Bunin, N., Abu-Arja, R., Mahadeo, K. M., Weng, W.-K., Van Besien, K., Loeb, D., Nasta, S. D., Nemecek, E. R., Zhao, W., Sun, Y., Galderisi, F., Wahlstrom, J., Mehta, A., Gamelin, L., Dinavahi, R., & Prockop, S. (2024). Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood Advances, 8(12), 3001–3012. https://doi.org/10.1182/bloodadvances.2023011626

Zinter, M. S., Dvorak, C. C., Mayday, M. Y., Reyes, G., Simon, M. R., Pearce, E. M., Kim, H., Shaw, P. J., Rowan, C. M., Auletta, J. J., Martin, P. L., Godder, K., Duncan, C. N., Lalefar, N. R., Kreml, E. M., Hume, J. R., Abdel-Azim, H., Hurley, C., … Cuvelier, G. D. E. (2024). Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation. Nature Medicine, 30(7), 1982–1993. https://doi.org/10.1038/s41591-024-02999-4

Frangoul, H., Locatelli, F., Sharma, A., Bhatia, M., Mapara, M., Molinari, L., Wall, D., Liem, R. I., Telfer, P., Shah, A. J., Cavazzana, M., Corbacioglu, S., Rondelli, D., Meisel, R., Dedeken, L., Lobitz, S., de Montalembert, M., Steinberg, M. H., Walters, M. C., … Grupp, S. A. (2024). Exagamglogene Autotemcel for Severe Sickle Cell Disease. New England Journal of Medicine, 390(18), 1649–1662. https://doi.org/10.1056/nejmoa2309676

Keller, M. D., Hanley, P. J., Chi, Y.-Y., Aguayo-Hiraldo, P., Dvorak, C. C., Verneris, M. R., Kohn, D. B., Pai, S.-Y., Dávila Saldaña, B. J., Hanisch, B., Quigg, T. C., Adams, R. H., Dahlberg, A., Chandrakasan, S., Hasan, H., Malvar, J., Jensen-Wachspress, M. A., Lazarski, C. A., Sani, G., … Pulsipher, M. A. (2024). Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-47057-2

Mata, J. R., Zahurak, M., Rosen, N., DeZern, A. E., Jones, R. J., & Ambinder, A. J. (2024). Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy, 30(6), 588–596. https://doi.org/10.1016/j.jtct.2024.03.018

Spyrou, N., Akahoshi, Y., Kowalyk, S., Morales, G., Beheshti, R., Aguayo-Hiraldo, P., Al Malki, M. M., Ayuk, F., Bader, P., Baez, J., Capellini, A., Choe, H., DeFilipp, Z., Eder, M., Eng, G., Etra, A., Gleich, S., Grupp, S. A., Hexner, E., … Ferrara, J. L. M. (2024). A Day 14 Endpoint for Acute GVHD Clinical Trials. Transplantation and Cellular Therapy, 30(4), 421–432. https://doi.org/10.1016/j.jtct.2024.01.079

Mahadeo, K. M., Baiocchi, R., Beitinjaneh, A., Chaganti, S., Choquet, S., Dierickx, D., Dinavahi, R., Duan, X., Gamelin, L., Ghobadi, A., Guzman-Becerra, N., Joshi, M., Mehta, A., Navarro, W. H., Nikiforow, S., O’Reilly, R. J., Reshef, R., Ruiz, F., Spindler, T., & Prockop, S. (2024). Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial. The Lancet Oncology, 25(3), 376–387. https://doi.org/10.1016/s1470-2045(23)00649-6

McCarthy, P. L., Attwood, K. M., Liu, X., Chen, G. L., Minderman, H., Alousi, A., Bashey, A., Lowsky, R., Miklos, D. B., Hansen, J., Westervelt, P., Yanik, G., Waller, E. K., Howard, A., Blazar, B. R., Wallace, P. K., Reshef, R., Horowitz, M. M., Maziarz, R. T., … Mohammadpour, H. (2023). Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone Marrow Transplantation, 59(3), 334–343. https://doi.org/10.1038/s41409-023-02168-0

Leiding, J. W., Arnold, D. E., Parikh, S., Logan, B., Marsh, R. A., Griffith, L. M., Wu, R., Kidd, S., Mallhi, K., Chellapandian, D., Si Lim, S. J., Grunebaum, E., Falcone, E. L., Murguia-Favela, L., Grossman, D., Prasad, V. K., Heimall, J. R., Touzot, F., Burroughs, L. M., … Kang, E. M. (2023). Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Blood, 142(24), 2105–2118. https://doi.org/10.1182/blood.2022019586

Chakraborty, R., Milani, P., Palladini, G., & Gertz, M. (2023). Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodies. The Lancet Haematology, 10(11), e936–e940. https://doi.org/10.1016/s2352-3026(23)00175-8

Al Malki, M. M., London, K., Baez, J., Akahoshi, Y., Hogan, W. J., Etra, A., Choe, H., Hexner, E., Langston, A., Abhyankar, S., Ponce, D. M., DeFilipp, Z., Kitko, C. L., Adekola, K., Reshef, R., Ayuk, F., Capellini, A., Chanswangphuwana, C., Eder, M., … Levine, J. E. (2023). Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Blood Advances, 7(17), 5189–5198. https://doi.org/10.1182/bloodadvances.2023009853

Xu, B., Gordillo, C. A., Delille, E. M., Malandrakis, S., Assal, A., Mapara, M. Y., & Reshef, R. (2023). Improved serologic responses to DTaP over Tdap vaccination in adult hematopoietic cell transplant recipients. European Journal of Haematology, 111(3), 499–505. Portico. https://doi.org/10.1111/ejh.14033

Zhai, N., Liu, W., Jin, C.-H., Ding, Y., Sun, L., Zhang, D., Wang, Z., Tang, Y., Zhao, W., LeGuern, C., Mapara, M. Y., Wang, H., & Yang, Y.-G. (2023). Lack of IFN-γ Receptor Signaling Inhibits Graft-versus-Host Disease by Potentiating Regulatory T Cell Expansion and Conversion. The Journal of Immunology, 211(5), 885–894. https://doi.org/10.4049/jimmunol.2200411

Gladstone, D. E., D’Alessio, F., Howard, C., Lyu, M.-A., Mock, J. R., Gibbs, K. W., Abrams, D., Huang, M., Zeng, K., Herlihy, J. P., Castillo, S. T., Bassett, R., Sadeghi, T., Parmar, S., Flowers, C. R., Mukherjee, S., Schoenfeld, D., Thall, P. F., & Slutsky, A. S. (2023). Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS. Blood Advances, 7(13), 3075–3079. https://doi.org/10.1182/bloodadvances.2022009619

Thakar, M. S., Logan, B. R., Puck, J. M., Dunn, E. A., Buckley, R. H., Cowan, M. J., O’Reilly, R. J., Kapoor, N., Satter, L. F., Pai, S.-Y., Heimall, J., Chandra, S., Ebens, C. L., Chellapandian, D., Williams, O., Burroughs, L. M., Saldana, B. D., Rayes, A., Madden, L. M., … Notarangelo, L. D. (2023). Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. The Lancet, 402(10396), 129–140. https://doi.org/10.1016/s0140-6736(23)00731-6

Murthy, G. S. G., Kim, S., Estrada-Merly, N., Abid, M. B., Aljurf, M., Assal, A., Badar, T., Badawy, S. M., Ballen, K., Beitinjaneh, A., Cerny, J., Chhabra, S., DeFilipp, Z., Dholaria, B., Perez, M. A. D., Farhan, S., Freytes, C. O., Gale, R. P., Ganguly, S., … Saber, W. (2023). Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis. Haematologica, 108(7), 1900–1908. https://doi.org/10.3324/haematol.2022.281958

Bolaños-Meade, J., Hamadani, M., Wu, J., Al Malki, M. M., Martens, M. J., Runaas, L., Elmariah, H., Rezvani, A. R., Gooptu, M., Larkin, K. T., Shaffer, B. C., El Jurdi, N., Loren, A. W., Solh, M., Hall, A. C., Alousi, A. M., Jamy, O. H., Perales, M.-A., Yao, J. M., … Holtan, S. G. (2023). Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. New England Journal of Medicine, 388(25), 2338–2348. https://doi.org/10.1056/nejmoa2215943

Chakraborty, R., Yi, J., Rybicki, L., Preussler, J., Deol, A., Loren, A., Savani, B., Jim, H. S. L., Cerny, J., Reynolds, J., Whitten, J., Wingard, J. R., McGuirk, J. P., Uberti, J., Khera, N., Stiff, P., Jaglowski, S. M., Hashmi, S., Holtan, S. G., … Majhail, N. S. (2023). Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Transplantation and Cellular Therapy, 29(6), 388.e1-388.e6. https://doi.org/10.1016/j.jtct.2023.02.011

Kinoshita, H., Mandava, M., Jensen-Wachspress, M., Lang, H., Joy, E., Tanna, J., McCann, C. D., O’Brien, S., Burnett, S., Shibli, A., Hoq, F., Bhatia, M., Hanley, P. J., Dávila Saldaña, B., Mahadeo, K. M., Bollard, C. M., Keller, M. D., & Abraham, A. (2023). Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease. Blood Advances, 7(10), 2105–2116. https://doi.org/10.1182/bloodadvances.2022008219

Picoli, C. C., Martins, P. R., Wong, X. L. C., Righi, T., Guimarães, P. P. G., Pinto, M. C. X., Amorim, J. H., Azevedo, V. A. C., Pereira, S. R., Kanashiro, A., Cruz, F. C., Resende, R. R., Mintz, A., Frenette, P. S., & Birbrair, A. (2022). Whole bone subcutaneous transplantation as a strategy to study precisely the bone marrow niche. Stem Cell Reviews and Reports, 19(4), 906–927. https://doi.org/10.1007/s12015-022-10496-9

Lehrnbecher, T., Robinson, P. D., Ammann, R. A., Fisher, B., Patel, P., Phillips, R., Beauchemin, M. P., Carlesse, F., Castagnola, E., Davis, B. L., Elgarten, C. W., Groll, A. H., Haeusler, G. M., Koenig, C., Santolaya, M. E., Tissing, W. J. E., Wolf, J., Alexander, S., Hu, H., … Sung, L. (2023). Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update. Journal of Clinical Oncology, 41(9), 1774–1785. https://doi.org/10.1200/jco.22.02224

Putta, S., Young, B. A., Levine, J. E., Reshef, R., Nakamura, R., Strouse, C., Perales, M.-A., Howard, A., Pine, P., Shi, J., Zhang, P., Ho, V. T., & Saber, W. (2023). Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study. Transplantation and Cellular Therapy, 29(3), 166.e1-166.e10. https://doi.org/10.1016/j.jtct.2022.11.024

Lyu, M.-A., Huang, M., Zeng, K., Li, L., Khoury, J. D., Nishimoto, M., Ma, H., Sadeghi, T., Mukherjee, S., Slutsky, A. S., Flowers, C. R., & Parmar, S. (2023). Allogeneic cord blood regulatory T cells can resolve lung inflammation. Cytotherapy, 25(3), 245–253. https://doi.org/10.1016/j.jcyt.2022.10.009

Sembill, S., Ampatzidou, M., Chaudhury, S., Dworzak, M., Kalwak, K., Karow, A., Kiani, A., Krumbholz, M., Luesink, M., Naumann-Bartsch, N., De Moerloose, B., Osborn, M., Schultz, K. R., Sedlacek, P., Giona, F., Zwaan, C. M., Shimada, H., Versluijs, B., Millot, F., … Metzler, M. (2023). Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations. Leukemia, 37(3), 505–517. https://doi.org/10.1038/s41375-023-01822-2

Wayne, A. S., Huynh, V., Hijiya, N., Rouce, R. H., Brown, P. A., Krueger, J., Kitko, C. L., Ziga, E. D., Hermiston, M. L., Richards, M. K., Baruchel, A., Schuberth, P. C., Rossi, J., Zhou, L., Goyal, L., Jain, R., Vezan, R., Masouleh, B. K., & Lee, D. W. (2022). Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia. Haematologica, 108(3), 747–760. https://doi.org/10.3324/haematol.2022.280678

Etra, A., Capellini, A., Alousi, A., Al Malki, M. M., Choe, H., DeFilipp, Z., Hogan, W. J., Kitko, C. L., Ayuk, F., Baez, J., Gandhi, I., Kasikis, S., Gleich, S., Hexner, E., Hoepting, M., Kapoor, U., Kowalyk, S., Kwon, D., Langston, A., … Levine, J. E. (2023). Effective treatment of low-risk acute GVHD with itacitinib monotherapy. Blood, 141(5), 481–489. https://doi.org/10.1182/blood.2022017442

Patel, C., Pasciolla, M., Abramova, R., Salerno, D., Gomez-Arteaga, A., Shore, T. B., Orfali, N., Mayer, S., Hsu, J., Phillips, A. A., Chaekal, O.-K., Satlin, M. J., Soave, R., Kodiyanplakkal, R. P. L., Drelick, A., Plate, M., & Besien, K. V. (2023). Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients. Transplantation and Cellular Therapy, 29(2), 132.e1-132.e5. https://doi.org/10.1016/j.jtct.2022.10.023

Cherng, H. J., Xu, G., Feng, L., Steiner, R., Fayad, L., Strati, P., Nair, R., Nastoupil, L. J., Lee, H. J., Neelapu, S. S., Flowers, C. R., Rodriguez, M., Wang, M., Hagemeister, F., Pinnix, C. C., Ramdial, J., Srour, S., Nieto, Y., Rezvani, K., … Ahmed, S. (2022). Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant. British Journal of Haematology, 200(1), 35–44. Portico. https://doi.org/10.1111/bjh.18441

Stenger, E., Xiang, Y., Wetzel, M., Gillespie, S., Chellapandian, D., Shah, R., Arnold, S. D., Bhatia, M., Chaudhury, S., Eckrich, M. J., Kanter, J., Kasow, K. A., Krajewski, J., Nickel, R. S., Ngwube, A. I., Olson, T. S., Rangarajan, H. G., Wobma, H., Guilcher, G. M. T., … Abraham, A. (2023). Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance. Transplantation and Cellular Therapy, 29(1), 47.e1-47.e10. https://doi.org/10.1016/j.jtct.2022.10.012

Landau, H. J., Orlando, E., Rodriguez, E. S., Applebaum, A., Mitchell, H.-R., Peled, J. U., Khan, N., Funnell, T., Chung, D., Scordo, M., Shah, G. L., LeStrange, N. J., Hambright, K. A., McElrath, C. M., Cazeau, N., Devlin, S. M., Perales, M.-A., van den Brink, M. R. M., & Giralt, S. A. (2022). Pilot Trial of Homebound Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(12), 832.e1-832.e7. https://doi.org/10.1016/j.jtct.2022.09.014

Savage, K. J., Horwitz, S. M., Advani, R., Christensen, J. H., Domingo-Domenech, E., Rossi, G., Morschhauser, F., Alpdogan, O., Suh, C., Tobinai, K., Shustov, A., Trneny, M., Yuen, S., Zinzani, P. L., Trümper, L., Ilidge, T., O’Connor, O. A., Pro, B., Miao, H., … Iyer, S. (2022). Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2. Blood Advances, 6(19), 5550–5555. https://doi.org/10.1182/bloodadvances.2020003971

Mishkin, A. D., Cheung, S. G., Hoffman, A., Leimbach, E. J., Dosovitz, S., & Mapara, M. (2022). High incidence of suicidal ideation in a series of patients with sickle cell disease after hematopoietic stem cell transplantation. Blood Advances, 6(19), 5542–5545. https://doi.org/10.1182/bloodadvances.2021006752

Lewis, J., Greenway, S. C., Khan, F., Singh, G., Bhatia, M., & Guilcher, G. M. T. (2022). Assessment of donor cell engraftment after hematopoietic stem cell transplantation for sickle cell disease: A review of current and future methods. American Journal of Hematology, 97(10), 1359–1371. Portico. https://doi.org/10.1002/ajh.26599

Otegbeye, F., Vina, M. A. F., Wang, T., Bolon, Y.-T., Lazaryan, A., Beitinjaneh, A., Bhatt, V. R., Castillo, P., Marsh, S. G. E., Hildebrandt, G. C., Assal, A., Brown, V. I., Hsu, J., Spellman, S., de Lima, M., & Lee, S. J. (2022). Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation. Transplantation and Cellular Therapy, 28(8), 483.e1-483.e7. https://doi.org/10.1016/j.jtct.2022.05.034

Kumar, S., Baizer, L., Callander, N. S., Giralt, S. A., Hillengass, J., Freidlin, B., Hoering, A., Richardson, P. G., Schwartz, E. I., Reiman, A., Lentzsch, S., McCarthy, P. L., Jagannath, S., Yee, A. J., Little, R. F., & Raje, N. S. (2022). Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee. Blood Cancer Journal, 12(6). https://doi.org/10.1038/s41408-022-00695-5

Etra, A., Gergoudis, S., Morales, G., Spyrou, N., Shah, J., Kowalyk, S., Ayuk, F., Baez, J., Chanswangphuwana, C., Chen, Y.-B., Choe, H., DeFilipp, Z., Gandhi, I., Hexner, E., Hogan, W. J., Holler, E., Kapoor, U., Kitko, C. L., Kraus, S., … Levine, J. E. (2022). Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood Advances, 6(12), 3707–3715. https://doi.org/10.1182/bloodadvances.2022007296

Chakraborty, R., Siddiqi, R., Willson, G., Gupta, S., Asghar, N., Husnain, M., Aljama, M. A., Behera, T. R., Anwer, F., Perrot, A., & Riaz, I. B. (2022). Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high‐risk cytogenetics: A meta‐analysis of randomized controlled trials. Cancer, 128(12), 2288–2297. Portico. https://doi.org/10.1002/cncr.34211